Avid Bioservices Inc (CDMO)

[biopharm]

EXOSOMES, largely under estimated!

I myself deeply under estimated the exosome pipeline, i mean its commercial potential and the fact that it would not only be partnered in H1/2017 but that it is ready to start manufacturing and sales after partnering with an FDA certified manufacturer, for this kind of tests, is signed.

Interesting post and CP, did you have the link for the Exosomes patent you were pointing to in item#2 ?

I was curious if the patent was assigned to Peregrine, now CDMO....and another party ....